NCT02273947View on ClinicalTrials.gov

Food Effect Study With BMS-955176

PHASE1CompletedINTERVENTIONAL

Enrollment

12

Participants

Timeline

Start Date

October 23, 2014

Primary Completion Date

August 15, 2016

Study Completion Date

August 15, 2016

Conditions

Infection, Human Immunodeficiency Virus

Interventions

DRUG

BMS-955176

Single dose by mouth for each treatment specified

Trial Locations (1)

NG11 6JS

GSK Investigational Site, Ruddington Fields

Sponsors

Lead Sponsor

ViiV Healthcare

Collaborators (1)

GlaxoSmithKline

All Listed Sponsors

collaborator

GlaxoSmithKline

INDUSTRY

lead

ViiV Healthcare

INDUSTRY

NCT02273947 - Food Effect Study With BMS-955176 | Biotech Hunter | Biotech Hunter